The Life Sciences Greenhouse of Central Pennsylvania this week said it has invested $250,000 in State College-based Indigo Biosciences, which has developed nuclear-receptor assays for use in drug discovery.
 
An Indigo official told CBA News this week that the firm will use the money to market its first product, a suite of frozen, single-use, cell-based, nuclear receptor assays designed to enable investigators to identify potential off-target effects of small-molecule drug candidates.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.